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Abstract
Background: Nontypeable Haemophilus influenzae is an important cause of otitis media in children
and lower respiratory tract infection in adults with chronic obstructive pulmonary disease (COPD).
Several lines of evidence suggest that the bacterium grows as a biofilm in the human respiratory
tract.
Results: Fifteen clinical isolates from middle ear fluid of children with otitis media and 15 isolates
from sputum of adults with COPD were studied in an in vitro assay of biofilm formation. Striking
variability among isolates was observed in their ability to form biofilms. Analysis of cell envelopes
revealed minimal differences in banding patterns in polyacrylamide gels, alteration of expression of
an epitope on lipooligosaccharide, and preservation of expression of selected epitopes on outer
membrane proteins P2, P5 and P6 in biofilms compared to planktonically grown cells. A pilus-
deficient variant showed a marked impairment in biofilm formation compared to its isogenic parent.
Conclusions: Nontypeable H. influenzae forms biofilms in vitro. Clinical isolates show substantial
variability in their ability to grow as biofilms. Three major outer membrane proteins (P2, P5 and
P6) are expressed during growth as a biofilm. Expression of lipooligosaccharide is altered during
growth as a biofilm compared to planktonic growth. Pili are important in biofilm formation. As the
role of biofilms in human infection becomes better defined, characterization of biofilms may be
important in understanding the pathogenesis of infection and immune response to nontypeable H.
influenzae in children with otitis media and adults with COPD.
Background
Nontypeable Haemophilus influenzae is an important hu-
man respiratory tract pathogen [1–4]. The bacterium caus-
es acute otitis media as established by pure culture of the
organism from middle ear fluid during disease [5–9]. In
addition, nontypeable H. influenzae has been implicated
as a cause of otitis media with effusion, which refers to the
presence of fluid in the middle ear in the absence of acute
symptoms. Acute otitis media and otitis media with effu-
sion represent an enormous health problem for children
worldwide [10–12]. A large amount of effort has been de-
voted to understanding the pathogenesis of otitis media
with a goal toward developing ways to prevent the disease
[1,13,14].
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Many middle ear fluids from children with otitis media
with effusion are sterile by culture. However, assays using
the polymerase chain reaction (PCR) have demonstrated
that DNA of nontypeable H. influenzae is present in a sub-
stantial proportion of these middle ear fluids [15–20].
Furthermore, reverse transcriptase PCR-based assays have
shown the presence of bacterial mRNA, indicating that
bacteria are present in a viable and metabolically active
but non-culturable state [21]. These observations suggest
that in otitis media with effusion, bacteria are in a physi-
ological state which differs from that of bacteria growing
planktonically in a free floating phase. Some authors have
proposed that in otitis media with effusion, nontypeable
H. influenzae grow in the form of a biofilm in the middle
ear [15,22,23].
A biofilm is a structured community of bacterial cells en-
veloped in a self-produced polymeric matrix and adherent
to an inert or living surface [22,24]. It is estimated that
99.9% of bacteria in nature are attached to a surface in the
form of a biofilm. Over the past decade bacteria in the
form of biofilms have been recognized as important caus-
es of a variety of human infections, including infections of
prosthetic devices, endocarditis, dental caries, pneumonia
in cystic fibrosis, prostatitis and others [22,25–28]. Bio-
films are more resistant to immune clearance mechanisms
and to antibiotics compared to planktonic bacteria
[29,30]. In order to develop strategies to treat and prevent
infections caused by bacteria in biofilms, including otitis
media with effusion, it will be important to elucidate the
characteristics of bacterial pathogens as biofilms.
In addition to being a common cause of otitis media, non-
typeable H. influenzae colonizes the lower respiratory tract
of adults with chronic obstructive pulmonary disease
(COPD) and is an important cause of exacerbations of the
disease [4,31]. An ongoing prospective study of bacterial
infection in COPD at the Buffalo Veterans Affairs Medical
Center has revealed interesting features regarding the dy-
namics of colonization in COPD. While active turnover of
new strains of nontypeable H. influenzae occurs, some
strains have the ability to persist for many months.
Monthly sputum cultures reveal intermittent negative cul-
tures in spite of continuous colonization by the same iso-
late proven by molecular typing, indicating that the
organism is present in spite of negative cultures of sputum
[32] (and authors unpublished observations). These ob-
servations suggest that nontypeable H. influenzae grows as
a biofilm in the respiratory tract of adults with COPD,
reminiscent of Pseudomonas aeruginosa and its well estab-
lished propensity to grow as a biofilm while causing infec-
tion in patients with cystic fibrosis [27].
In view of these lines of evidence suggesting that nontype-
able H influenzae grows as a biofilm during human respi-
ratory tract infection, the goals of the present study are to
1) Develop an assay to study biofilms of nontypeable H.
influenzae in vitro; 2) Characterize the extent to which iso-
lates from the middle ear fluid of children with otitis me-
dia and from the sputum of adults with COPD form
biofilms; 3) Begin to elucidate the characteristics of the
outer membrane antigens of nontypeable H. influenzae
during growth as a biofilm; and 4) Preliminarily assess the
role of pili in biofilm formation.
Results
Biofilm formation by clinical isolates
Fifteen isolates recovered from the sputum of adults with
COPD and 15 isolates recovered from the middle ear fluid
of children with otitis media were studied for biofilm for-
mation. Figure 1a and 1b show that striking differences
were observed among strains with regard to the ability to
form biofilms. Values depicted in the bar graphs represent
the mean of three independent experiments performed in
quadriplicate. The error bars represent the standard devia-
tion. Although some variability in values was seen, the
level of biofilm formation was highly consistent from ex-
periment to experiment. Strains which formed good bio-
films (e.g., strains 5P11H1, 6P8H1, 13P26H1, 31P13H1,
56P40H1 and 74P10H1 from Figure 1b) and strains
which formed poor biofims (e.g., 5P10H1, 6P5H,
7P49H1, 6P32H1 and 13P33H1) do so consistently. In-
spection of Figure 1 reveals that one cannot readily divide
strains into those which form biofilms and those which
do not. Rather, a broad range of ability to form biofilms
was seen among these randomly chosen 30 clinical iso-
lates.
Conditions for biofilm formation
In an effort to identify growth conditions which might re-
sult in increased biofilm formation, eight strains which
showed a range of ability to form biofilms were chosen for
further study. The strains included 4 isolates from middle
ear fluid (955, 1826, 1749, 9289) and 4 isolates from the
sputum of adults with COPD (74P10H1, 5P11H1,
5P10H1, 14P13H1). The following reagents were added
individually to aliquots of media: 2% glucose, 5% glu-
cose, 2% sucrose, 5% sucrose, 0.2 M NaCl, 2% ethanol. A
biofilm assay was performed and the results were com-
pared with biofilms in growth media for each of the
strains. None of the added reagents caused an increase in
biofilm formation for any of the strains.
Biofilm growth curve
To characterize the kinetics of biofilm formation, the level
of biofilm formation was measured at selected time
points over a 24 hour period for 4 strains. Figure 2 shows
that a gradual increase in biofilm is seen over approxi-
mately 16 hours. After approximately 16 hours, biofilm
formation shows a leveling off and the optical density re-BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/7
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mains relatively stable to 24 hours at an optical density
which is characteristic of each of the 4 strains.
Expression of outer membrane antigens during growth as 
a biofilm
To preliminarily assess the expression of outer membrane
antigens by nontypeable H. influenzae during growth as
biofilms, cell envelopes of strain 74P10H1 grown as a bi-
ofilm in a 24 well plate were purified. Simultaneously, cell
envelopes of strain 74P10H1 grown on agar plates were
purified by the same method. Figure 3 is a Coomassie blue
stained gel of cell envelopes of strain 74P10H1 grown on
agar medium compared to cell envelopes of the same
strain grown as a biofilm. Differences are noted in minor
bands and differences in the intensity of bands are noted.
The major bands appear similar in the two preparations.
To further assess the expression of epitopes on selected in-
dividual outer membrane antigens, purified cell enve-
lopes were assayed in immunoblot assays with well
characterized polyclonal and monoclonal antibodies.
Polyclonal antibodies to a peptide corresponding to loop
6 of the outer membrane protein P2 [33], which is the
only known porin of nontypeable H. influenzae, revealed
expression of P2 in the bacteria grown as a biofilm and in
planktonically grown bacteria (Figure 4). Similarly, the
epitopes recognized by monoclonal antibodies to outer
membrane protein P5, an OMP A-like protein, and P6, a
highly conserved protein in all strains of nontypeable H.
influenzae, were expressed in the outer membranes of cells
grown as biofilms and cells grown planktonically (Figure
4).
Figure 1
Biofilm formation by clinical isolates of nontypeable H. influ-
enzae. Bars represent the means of three independent exper-
iments performed in quadruplicate. Error bars represent
standard deviation. Y axis is optical density at 570 nm. la:
middle ear isolates: a. 83; b. 955; c. 1128; d. 1749; e. 1826; f.
2536; g. 2846; h. C4556; i. 8131; j. 8183; k. 8981; 1. 9289; m.
C1425; n. DL200; o. 4505. 1b: sputum isolates: a. 5P10H1; b.
5P11H1; c. 5P30H; d. 6P5H; e. 6P8H1; f. 13P26H1; g.
14P13H5; h. 31P13H1; i. 56P40Hl; j. 74P10H1; k. 7P49H1; l.



















a.  middle ear isolates




















  a   b  c   d  e   f   g   h   i   j   k   l   m  n  o
Figure 2
Time course of biofilm formation by four strains of nontype-
able H. influenzae as noted on the right. X axis: time in hours.
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When bacteria were grown on agar plates using the same
media as for growth in biofilms (brain heart infusion +
hemin + nicotinamide adenine dinucleotide), the expres-
sion of a lipooligosaccharide epitope was reduced com-
pared to the level of expression in biofilms (Figure 4). This
epitope appears to be expressed at similar levels as in bio-
films when the bacteria are grown on chocolate agar and
in brain heart infusion broth (data not shown). Bacteria
grow more slowly on the brain heart infusion agar com-
pared to chocolate agar. The observation that the expres-
sion of epitopes on outer membrane proteins P2, P5 and
P6 was similar in biofilms and agar (Figure 4) indicates
that the alteration in expression of the epitope on lipooli-
gosaccharide is not explained by slow growth, but repre-
sents altered expression of lipooligosacharide under
different growth conditions.
Role of pili in biofilm formation
To assess the potential role of pili in biofilm formation, a
variant of a strain of nontypeable H. influenzae which
lacks expression of pili was tested for biofilm formation
along with its isogenic parent strain. Strain M37-1 lacks
expression of pili as indicated by absence of hemaggluti-
nation and absence of a 22 kDa band on SDS-PAGE cor-
responding to pilin [34]. In an experiment comparing
biofilm formation in 4 duplicate wells, strain M37-1, the
pilus deficient variant, yielded an average optical density
of 0.204 whereas its isogenic parent strain, M37, yielded
an average optical density of 0.884. This experiment was
repeated multiple times and the pilus deficient variant
showed a 3 to 4 fold decrease in biofilm formation com-
pared to its isogenic parent strain in every experiment.
Discussion
Assays of 30 randomly chosen clinical isolates from the
middle ear of children with otitis media and from the spu-
tum of adults with COPD show that isolates of nontypea-
ble H. influenzae demonstrate striking differences in their
propensity to grow as biofilms in vitro. These differences
are highly reproducible in that individual isolates show
similar levels of biofilm formation on repeated experi-
ments
The assay for biofilm formation used in this study is based
on the ability of bacteria to adhere to plastic wells in mi-
crotiter plates. This method has been used to study bio-
film formation by a variety of other gram-positive and
gram-negative bacteria [35–38]. The method has both ad-
vantages and disadvantages compared to studying biofilm
formation in flow cells, the other widely used method.
The microtiter plate assay yields reproducible results and
is convenient, allowing one to study large numbers of
strains and conditions. Furthermore, the method yields
quantitative results, based on measuring the optical den-
sity of wells. An important potential limitation of the mi-
Figure 3
Coomassie blue stained sodium dodecyl sulfate polyacryla-
mide gel of cell envelopes of nontypeable H. influenzae
74P10H1 grown on agar plates (lane a) and as a biofilm (lane
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crotiter plate method is that one might question whether
the method is capable of distinguishing true biofilm for-
mation from bacteria simply adhering to plastic wells.
Two lines of evidence suggest that the method is measur-
ing biofilm formation. First, Watnick and Kolter [36]
showed by confocal laser microscopy that the morpholo-
gy of biofilms of Vibrio cholerae grown on cover slips in
static culture is similar to the morphology of biofilms
grown in a flow cell. And second, with regard to this study,
the protein patterns in SDS polyacrylamide gel electro-
phoresis and expression of lipooligosaccharide epitopes
are different in bacteria recovered from biofilms grown in
micotiter wells compared to planktonic cells grown in me-
dia. These observations suggest that the assay is detecting
bacteria as biofilms rather than simply measuring plank-
tonic bacteria adhering to plastic wells. However, more
definitive answers regarding biofilm formation in human
infection caused by nontypeable H. influenzae awaits de-
tailed studies involving confocal laser microscopy of clin-
ical samples containing the organism.
The importance of nontypeable H. influenzae as a human
respiratory tract pathogen, has stimulated a large body of
research to elucidate the antigenic characteristics of the
outer membrane of the organism. This work is important
in understanding mechanisms of pathogenesis, character-
izing the human immune response to infection and guid-
ing vaccine development. This large body of work has
been performed exclusively on bacteria grown planktoni-
cally. In view of the mounting evidence that nontypeable
H. influenzae grows as a biofilm in otitis media with effu-
sion and in the respiratory tract of adults with COPD, it
will be important to characterize the bacterial surface an-
tigens of the organism during growth as a biofilm. The
present study used well characterized polyclonal and
Figure 4
Immunoblot assays of cell envelopes of nontypeable H. influenzae 74P10H1 grown on agar plates (lanes a) and as a biofilm
(lanes b). Panels were probed with antibodies to outer membrane antigens as follows: P2: rabbit polyclonal antiserum raised to
loop 6 of P2; P5: monoclonal antibody 2C7; P6: monoclonal antibody 7F3; LOS (lipooligosaccharide): monoclonal antibody 6E4.
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monoclonal antibodies to begin to address this important
question.
P2, the major outer membrane protein in the outer mem-
brane is the only known porin protein of H. influenzae.
Immunoblot assays with antiserum raised to a conserved
surface exposed loop of P2 showed that expression of P2
was similar in amount, molecular mass, and immunore-
activity in bacteria grown planktonically and as a biofilm.
This observation is in contrast to expression of porin pro-
teins of Escherichia coli and Pseudomonas aeruginosa whose
expression are altered during growth as a biofilm [38,39].
Similarly, expression of outer membrane protein P5, an
OMP A-like protein, and P6, a highly conserved 16 kDa
protein, is preserved in cells grown as biofilms based on
immunoblot assays with monoclonal antibodies (Figure
4). The expression of P5 and P6 in biofilms is especially
important since these proteins are under consideration as
vaccine antigens. Finally, alteration of expression of an
epitope on lipooligosaccharide suggests that the organism
expresses a different lipooligosaccharide molecule during
growth as a biofilm. Similarly, expression of lipopolysac-
charide of Pseudomonas aeruginosa is altered during growth
as biofilms [40]. These studies of outer membrane antigen
expression are limited by the sensitivity of immunoblot
assays. While the assays establish that P2, P5 and P6 and
the epitopes recognized by the antibodies are expressed in
biofilms and that expression of lipooligosaccharide is al-
tered, one must be cautious in drawing firm conclusions
regarding the level of expression and the surface accessi-
bility of the epitopes recognized by the antibodies based
on results of immunoblot assays alone because they are
not quantitative assays.
An isogenic variant of nontypeable H. influenzae deficient
in expression in pili showed a marked reduction in the
ability to grow as a biofilm. This observation parallels that
made in several other bacterial species showing the pili are
critical in the early stages of biofilm formation [36,41].
This paper is the first report of formation of biofilms by H.
influenzae. Work on biofilm formation by nontypeable H.
influenzae should focus in several areas. It will be impor-
tant to define more precisely the extent to which the or-
ganism grows as biofilms during colonization and
infection of the human respiratory tract. The biofilm of
many bacterial species is composed of extracellular
polysaccharide such as capsule [42,43]. Since nontypea-
ble H. influenzae does not express a capsule, it will be in-
teresting to characterize the composition of the biofilm.
As the role of biofilms in human infection becomes better
defined, elucidating the human immune response to anti-
gens expressed during growth as biofilms may be impor-
tant in understanding host responses and in devising
strategies to prevent infection by nontypeable H. influen-
zae.
Conclusions
Nontypeable Haemophilus influenzae forms biofilms in vit-
ro. Clinical isolates show substantial variability in their
ability to grow as biofilms. Three major outer membrane
proteins, P2, P5 and P6, are expressed during growth as a
biofilm. Expression of an epitope on lipooligosaccharide
is altered during growth as a biofilm. Pili are important in
biofilm formation. As the role of biofilms in human infec-
tion becomes better defined, characterization of biofilms
may be important in understanding the pathogenesis of
infection and immune response to nontypeable H. influ-
enzae in children with otitis media and adults with COPD.
Materials and methods
Bacterial strains
A total of 30 isolates of nontypeable H. influenzae were
studied. Fifteen were isolated from the sputum of 11
adults with COPD as part of a prospective study being
conducted at the Buffalo Veterans Affairs Medical Center.
The isolates recovered from the same patient were proven
to be distinct strains of nontypeable H. influenzae based
on outer membrane protein patterns [32,44]. Fifteen iso-
lates were recovered from the middle ear fluids obtained
by tympanocentesis from children with otitis media.
Twelve were from Buffalo, New York; 1 from Columbus,
Ohio; 1 from Seattle, Washington; and 1 from Dallas, Tex-
as.
Nontypeable H. influenzae strain M37 and an isogenic var-
iant designated M37-1 which is deficient in expression of
pili were kindly provided by Robert Munson [34].
Bacteria were grown on chocolate agar or in brain heart in-
fusion broth supplemented with hemin and nicotinamide
adenine dinucleotide both at 10 µg/ml. In the experi-
ments to compare cell envelopes of bacteria grown plank-
tonically with those grown as biofilms, bacteria were
grown on brain heart infusion agar supplemented as not-
ed above. Media was supplemented with glucose, sucrose,
NaCl and ethanol in selected experiments as described in
the Results.
Biofilm growth assay
The assay to grow and quantitate nontypeable H. influen-
zae biofilms was essentially the same assay which has
been used for several other bacterial species [35–38]. An
overnight broth culture was diluted 1:200 in fresh broth
and 200 µl was inoculated into the wells of a 96 well Lin-
bro tissue culture plate (ICN Biomedical, Inc., Aurora,
Ohio). The plates were incubated at 37°C under 5% CO2
for 24 hours. Before biofilm quantitation, growth was as-
sessed by measuring the optical density at 490 nmBMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/7
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(OD490) in a BioRad plate reader. To quantitate biofilm
formation, 20 µl of Difco crystal violet (Becton Dickinson,
Sparks, Maryland) was added to each well and incubated
at room temperature for 15 minutes. Wells were washed
vigorously with distilled water and the plate was air dried.
A volume of 230 µl of 95% ethanol was added to each
well and the OD570 was measured. All strains were tested
in quadruplicate. Each plate included 4 wells which con-
tained sterile broth instead of bacteria but were treated
identically otherwise. The OD570 was standardized
against these wells.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS PAGE) and immunoblot assays
Cell envelopes were subjected to SDS PAGE and Coomas-
sie blue staining using previously described methods [44].
Immunoblot assays were performed as described previ-
ously [45]. After incubating with the antibodies, blots
were developed with the appropriate murine or rabbit
peroxidase conjugated secondary antibody.
Purification of cell envelopes
To study the outer membrane of nontypeable H. influen-
zae, bacteria were grown as a biofilm overnight in a 24
well Linbro tissue culture plate. Broth was aspirated and
the wells were washed 3 times with 1 ml of 0.01 M HEPES,
pH 7.4. Bacteria in the biofilm were harvested by scraping
the wells with the tip of a 1 ml micropipette tip. To pre-
pare cell envelopes, cells were suspended in 0.01 M
HEPES, pH 7.4 and sonicated on ice by using a Branson
Sonifier (small tip, setting 7) [44]. The suspension was
centrifuged at 12,000 x g for 2 minutes at 4°C to remove
unbroken cells and debris. The supernatant was recovered
and centrifuged at 12,000 x g for 45 minutes. The resulting
pellet was suspended in sample buffer and subjected to
SDS-PAGE and immunoblot assay.
Monoclonal and polyclonal antibodies
Monoclonal antibody (mab) 7F3 recognizes a surface ex-
posed epitope on outer membrane protein P6 [45,46].
Mab 6E4 (Provided by Alan Lesse) recognizes an epitope
on lipooligosaccharide [47]. Mab 2C7 (provided by Alan
Lesse) recognizes an epitope on outer membrane protein
P5. Rabbit polyclonal antiserum raised to a peptide corre-
sponding to loop 6 of outer membrane protein P2 recog-
nizes P2 of many strains of nontypeable H. influenzae was
described previously [33].
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